Connect with us
[ad_1] As we head into the third winter of the pandemic, only about 13% of American adults — less than 11% of Americans overall — have...
[ad_1] First the good news: Pfizer Inc. and Germany-based partner BioNTech SE said updated trial data for their omicron BA.4/BA.5-adapted bivalent booster showed a “substantially higher”...